Advertisement
Advertisement
EIKN
E
Eikon Therapeutics, Inc. Common Stock
12.29
USDSponsored
+0.76
+6.58%
May 13, 15:54 UTC -4
Open
EIKN Earnings Reports
Positive Surprise Ratio
No Data Available for EIKN
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Eikon Therapeutics, Inc. Common Stock earnings per share and revenue
On May 11, 2026, EIKN reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -1.77 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
eXp World Holdings, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.03
Surprise
+55.88%
ARKO Petroleum Corp. Class A Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
$0.18
Actual
$0.20
Surprise
+7.07%
Novanta Inc. Tangible Equity Units
Report Date
May 11, 2026 For Q1 26
Estimate
$0.79
Actual
$0.81
Surprise
+2.25%
Swarmer, Inc Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.28
Surprise
-149.55%
Gladstone Investment Corporation 4.875% Notes due 2028
Report Date
May 12, 2026 For Q4 26
Estimate
$0.21
Actual
$0.20
Surprise
-8.80%
Gladstone Investment Corporation 7.875% Notes due 2030
Report Date
May 12, 2026 For Q4 26
Estimate
$0.21
Actual
$0.20
Surprise
-8.80%
Gladstone Land Corporation 6.00% Series B Cumulative Redeemable Preferred Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.23
Actual
$0.08
Surprise
+134.60%
Emera Incorporated
Report Date
May 08, 2026 For Q1 26
Estimate
$1.15
Actual
$1.37
Surprise
+18.46%
WhiteHorse Finance, Inc. 7.875% Notes due 2028
Report Date
May 07, 2026 For Q1 26
Estimate
$0.28
Actual
$0.25
Surprise
-11.88%
FAQ
What were Eikon Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Eikon Therapeutics, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Eikon Therapeutics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Eikon Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Eikon Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Eikon Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement